SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to CEO Lisa Su's bullish outlook on AI data center revenue, projecting significant growth and market share gains, sparking excitement about AMD's potential in the AI sector. The community is actively discussing the company's prospects, comparing it to NVDA, and debating potential price targets, with some expressing concerns about overvaluation and potential pullbacks after the investor day. There is also speculation about new partnerships and increased competition in the AI chip market.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards due to lowered revenue guidance attributed to supply chain delays, sparking concerns despite strong AI-driven demand and a substantial backlog. Community discussions revolve around the severity of the delay's impact and comparisons to competitors, with some investors expressing long-term confidence while others weigh the risks amid broader AI sector volatility. Analyst downgrades and insider selling are adding to the negative sentiment.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as traders discuss a potential short squeeze, fueled by bullish technical indicators like a MACD crossover and a bull flag pattern on the daily chart. Community members are highlighting upcoming warrant distributions and perceived insider buying as catalysts, while also noting the company's AI-driven turnaround strategy. Some are speculating about a potential partnership with Robinhood and expressing excitement about the new CEO's vision.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to a volatile reaction to earnings and news of a $3 billion AI infrastructure deal with Meta, with community members debating the significance of the deal versus concerns about dilution and capacity constraints. While some see the dip as a buying opportunity given the long-term potential and growing demand for AI infrastructure, others are wary, pointing to market-wide concerns about an AI bubble and the company's execution risks. The stock's high volatility is also a key talking point.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending amid anticipation for a potential decision from the EMA on Blarcamesine, its Alzheimer's drug, with the community closely watching for news and speculating on the likelihood of approval. Recent discussions revolve around an upcoming oral explanation to the EMA which is perceived as either an opportunity to address concerns or a sign of potential setbacks, leading to heightened volatility and mixed sentiment. Despite the uncertainty, many express long-term confidence in the drug's potential, citing its safety profile and possible benefits for patients.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. is experiencing significant upward momentum, triggering community discussion around a potential short squeeze. This follows news of the company's acquisition of Damora Therapeutics and a substantial private placement. Traders are closely watching for continuation patterns and potential price targets, with some highlighting the stock's low float and high short interest as catalysts for further gains.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin ($APP) is trending amidst recent volatility, with community members actively discussing dip-buying opportunities and potential for a turnaround. Traders are weighing in on support levels and debating whether the stock's price action is driven by fundamentals, technical factors, or market manipulation. Optimistic sentiments remain, as some believe in a long-term growth trajectory for the stock.

Waton Financial Ltd. is a holding company, which engages in the provision of securities brokerage and financial technology services. It is also involved in software licensing and related support services including the licensing of trading platform app, upgrades and enhancements, maintenance, and other related services to financial institutions. The company was founded on June 25, 2010 and is headquartered in Hong Kong.

Waton Financial Ltd.

Waton Financial Ltd

Waton Financial ($WTF) is trending primarily due to community interest in its ticker symbol and speculation around its potential in AI and Web3. Recent news highlights the company's launch of an AI trading system and expansion into digital assets, sparking discussions about its fintech strategy. The community is closely watching for significant price movement and potential breakouts.

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

enGene Holdings Inc

ENGN is trending due to positive data from its bladder cancer study, with the community actively discussing its potential for a short squeeze given the high cost to borrow and low float. Some traders are setting stop losses and sell orders, while others believe institutional investment signals a potential reprice. Analyst upgrades and the potential for a significant price increase are also fueling interest.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as traders discuss potential short squeezes and speculate on buyout offers, especially following news of a bidding war for a competitor. Community members highlight the company's pipeline and cash reserves, with some suggesting price targets well above the current trading price. The stock is also gaining attention within the obesity drug sector, with traders watching for a potential breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


tgtex

NIELS HANNES SCHOENROCK